Sunitinib-Related Osteonecrosis of the External Auditory Canal: Case Report

Abstract

Keywords

osteonecrosis sunitinib temporal bone osteonecrosis skull base

Get full access to this article

View all access options for this article.

References

Marx

. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61(9):1115-1117. doi:10.1016/S0278-2391(03)00720-1

Polizzotto

Cousins

Schwarer

. Bisphosphonate-associated osteonecrosis of the auditory canal. Br J Haematol. 2006;132(1):114. doi:10.1111/j.1365-2141.2005.05833.x

Ruggiero

Dodson

Fantasia

, et al. American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg. 2014;72(10):1938-1956. doi:10.1016/j.joms.2014.04.031

Vallina

Ramírez

Torres

Casañas

Hernández

López-Pintor

. Osteonecrosis of the jaws produced by sunitinib: a systematic review. Med Oral Patol Oral Cir Bucal. 2019;24(3):e326-e338. doi:10.4317/medoral.22858

Canzano

Di Lella

Manuguerra

Vincenti

. Osteonecrosis of the external auditory canal associated with oral sorafenib therapy: sorafenib and temporal bone osteonecrosis. Otol Neurotol. 2019;40(8):E812-E815. doi:10.1097/MAO.0000000000002344